Today has been released the report “Lives Saved Report - Integrating harm reduction into tobacco control”, indicating that significant lives can be saved through the widespread adoption of THR and…
During the 2022 edition of GTNF, the Global Tobacco and Nicotine Forum, Prof. Riccardo Polosa, founder of the CoEHAR, was part of an intense and engaging panel on vaping and tobacco policies at the panel “Banned! Is Prohibition Back?”.
An independent review by the Replica project team examines the impact of tobacco smoke and electronic nicotine delivery systems use on oxidative stress, the precursor of the so-called tobacco related diseases (respiratory and cardiovascular diseases, tumors). To date, the scientific evidence available constitutes a puzzle of information, which, despite experimental and procedural limitations of international studies , already shows a reduced impact of ENDS on oxidative stress compared to cigarette smoking, even if some research have concluded that they do not completely eliminate it, leaving the question still pending
The meeting “75th Tobacco Science Research Conference” is an incredible opportunity for researchers and professionals to discuss, analyze and deepen the latest news on tobacco harm reduction strategies, including the necessary steps to develop the scientific activity and the engagement of the sector
According to Giovanni Li Volti, director of CoEHAR, the Center of Excellence for the Acceleration of Harm Reduction in Catania, "To date, the results that have emerged confirm that there are no longer any doubts: electronic cigarettes are more than 95% less harmful than conventional cigarettes”
The main goal of the protocol, the research project plan, is to examine the scientific evidence on the effects of e-cigarettes on smokers from the available studies. The project includes writing a paper for doctors and health care providers, a fact sheet for people who use e-cigarettes, and a policy brief for legislators on health committees
CoEHAR's researchers have just published the longest clinical follow-up of E-cigarette users ever reported. The study “COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up” explores the long term effects of E-cigarette use in patients with chronic obstructive pulmonary disease (COPD) and confirms that regular use can ameliorate objective and subjective COPD and is long lasting